VictoryShares US 500 Enhanced Volatility Wtd ETF

72.38

+0.73151.02%

Volume:6.75K

Turnover:487.37K

Market Cap:416.18M

PE:361.89

High:72.39

Open:72.09

Low:71.95

Close:71.65

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Press Release: BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors

Dow Jones

·

Yesterday

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CFO"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CFO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","market":"US","secType":"STK","nameCN":"VictoryShares US 500 Enhanced Volatility Wtd ETF","latestPrice":72.3788,"timestamp":1753214400000,"preClose":71.6473,"halted":0,"volume":6746,"delay":0,"floatShares":5750000,"shares":5750000,"eps":0.2,"marketStatus":"Pre-Mkt","change":0.7315,"latestTime":"07-23 05:41:16 EDT","open":72.09,"high":72.385,"low":71.9477,"amount":487371.273144,"amplitude":0.006104,"askPrice":82.84,"askSize":100,"bidPrice":62.27,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0.2,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1753277400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":72.3788,"sharesOutstanding":5750000,"nav":71.625744,"aum":411847775,"dividendRate":0.013125,"bidAskSpread":0.001146,"postHourTrading":{"tag":"盘后","latestPrice":72.32,"preClose":72.3788,"latestTime":"17:58 EDT","volume":5,"amount":356.92,"timestamp":1753221502019},"volumeRatio":0.908283046853711,"impliedVol":0.0718,"impliedVolPercentile":0.759},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CFO\",,,,,undefined,":{"symbol":"CFO","floatShares":5750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.908283046853711,"shares":5750000,"dividePrice":0.95,"high":72.385,"amplitude":0.006104,"preClose":71.6473,"low":71.9477,"week52Low":60.03,"pbRate":"--","week52High":74.0723,"institutionHeld":0,"latestPrice":72.3788,"eps":0.2,"divideRate":0.013125,"volume":6746,"delay":0,"ttmEps":0.2,"open":72.09,"prevYearClose":68.94,"prevWeekClose":71.8847,"prevMonthClose":71.29,"prevQuarterClose":71.29,"fiveDayClose":71.03,"twentyDayClose":69.94,"sixtyDayClose":66.2567},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CFO\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CFO\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553253485","title":"Press Release: BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2553253485","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553253485?lang=en_us&edition=fundamental","pubTime":"2025-07-22 20:00","pubTimestamp":1753185600,"startTime":"0","endTime":"0","summary":"CARSON CITY, Nev., July 22, 2025  -- BioVie Inc.  , a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the appointment of Amy S. Chappell, MD, FAAN, and Kameel D. Farag to its Board of Directors.\"Amy and Kameel each bring an extraordinary combination of strategic vision, operational excellence, and hands-on experience developing and commercializing therapies in complex neurological and chronic diseases,\" said Cuong Do, President and Chief Executive Officer  of BioVie Inc. \"As BioVie continues to advance bezisterim through Phase 2 trials for early Parkinson's disease and long COVID, and plans the next steps in clinical development in our Alzheimer's disease and ascites programs, their expertise will be invaluable in achieving our mission of transforming the treatment of these devastating conditions.\". These appointments come at a time of growing momentum for BioVie. T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","CFO","IPO","MD","R","BIVI","BK4139","BK4135","BK4022","CEO","CNS","BK4232"],"gpt_icon":0},{"id":"2552912284","title":"Under-fire NAB boss set to return to public eye amid turmoil","url":"https://stock-news.laohu8.com/highlight/detail?id=2552912284","media":"The Sydney Morning Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552912284?lang=en_us&edition=fundamental","pubTime":"2025-07-18 10:54","pubTimestamp":1752807240,"startTime":"0","endTime":"0","summary":"NAB has denied that chief executive Andrew Irvine is undergoing mentoring ahead of his first public appearance next week amid concerns raised by some of the bank’s investors about his behaviour and le","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/under-fire-nab-boss-set-to-return-to-public-eye-amid-turmoil-20250718-p5mfxb.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["XJO.AU","CFO.AU","BK7023","XAO.AU","XKO.AU","BK7123","ABA.AU","CFO","BK7139"],"gpt_icon":0},{"id":"2552431175","title":"Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2552431175","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552431175?lang=en_us&edition=fundamental","pubTime":"2025-07-18 04:05","pubTimestamp":1752782700,"startTime":"0","endTime":"0","summary":"CHASKA, Minn., July  17, 2025  (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117599/23089/en/Lifecore-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".IXIC","BK4121","LU2210149790.SGD","IE00BKPKM429.USD","LU2095319765.USD","BK4112","CFO","IE00BGHQF748.EUR","CDMO","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4585","LU2210150020.SGD","BK4212","BK4139","LFCR","BK4588","NDAQ"],"gpt_icon":0},{"id":"2552883944","title":"10 Growth Stocks Down 10% or More to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2552883944","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552883944?lang=en_us&edition=fundamental","pubTime":"2025-07-17 18:02","pubTimestamp":1752746520,"startTime":"0","endTime":"0","summary":"However, these promising growth stocks have yet to set new highs.Although they haven't kept pace with the S&P 500 recently, these stocks offer investors market-beating potential over the long term.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/17/10-growth-stocks-down-10-or-more-to-buy-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4566","LU2063271972.USD","LU0823434583.USD","LU1861558580.USD","LU0823434740.USD","LU0345774631.USD","SHOP","BK4548","LU1804176565.USD","ASML","BK4524","03165","LU0823421416.USD","BK4551","LU0823421333.USD","BK4211","LU2357305700.SGD","IPO","LU1720051017.SGD","LU1861559042.SGD","BK4543","BK4588","BK4585","BK4204","CFO","FCF","BK4539","LU0345774391.USD","IE0004445239.USD","BK4528","LU0081259029.USD","BK4147","LU0390134368.USD","LU1548497426.USD","LU1691799644.USD","LU0097036916.USD","BK4116","BK4532","LU1734074674.USD","BK4613","LU1720051108.HKD","IE00BD6J9T35.USD","LU2265009873.SGD","DUOL"],"gpt_icon":1}],"pageSize":4,"totalPage":42,"pageCount":1,"totalSize":165,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CFO\",params:#limit:5,,,undefined,":[{"date":"2025-07-10","symbol":"CFO","amount":0.085627,"announcedDate":"2025-07-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-10","defaultRemindTime":1752154200000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-11","payableDate":"2025-07-10","currency":"USD","dateTimestamp":1752120000000,"payDate":"2025-07-11"},{"date":"2025-06-09","symbol":"CFO","amount":0.11262,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-09","defaultRemindTime":1749475800000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-10","payableDate":"2025-06-09","currency":"USD","dateTimestamp":1749441600000,"payDate":"2025-06-10"},{"date":"2025-05-08","symbol":"CFO","amount":0.03005,"announcedDate":"2025-05-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-08","defaultRemindTime":1746711000000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-09","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746676800000,"payDate":"2025-05-09"},{"date":"2025-04-10","symbol":"CFO","amount":0.09739,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-10","defaultRemindTime":1744291800000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-11","payableDate":"2025-04-10","currency":"USD","dateTimestamp":1744257600000,"payDate":"2025-04-11"},{"date":"2025-03-10","symbol":"CFO","amount":0.1,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-10","defaultRemindTime":1741613400000,"name":"VictoryShares US 500 Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-11","payableDate":"2025-03-10","currency":"USD","dateTimestamp":1741579200000,"payDate":"2025-03-11"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CFO\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-22","recordDate":"2015-09-24","paymentDate":"2015-09-25","value":0.1092497,"currency":"USD"},{"executeDate":"2015-12-28","recordDate":"2015-12-30","paymentDate":"2015-12-31","value":0.1653246,"currency":"USD"},{"executeDate":"2016-03-08","recordDate":"2016-03-10","paymentDate":"2016-03-11","value":0.1177036,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-17","value":0.1457861,"currency":"USD"},{"executeDate":"2016-09-07","recordDate":"2016-09-09","paymentDate":"2016-09-12","value":0.1089324,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CFO\",market:\"US\",delay:false,,,undefined,":{}}}